Goldenwell Biotech annual revenue
2019
2020
2021
2022
2023
2024
2025
Goldenwell Biotech Revenue Growth & History (GWLL)
Goldenwell Biotech reported $55 in revenue for fiscal 2025, a decrease of 60.43% from the previous fiscal year.
View full Goldenwell Biotech company overviewGoldenwell Biotech annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $55 | −$84 | −60.43% |
| 2024 | 2024-12-31 | $139 | −$2,201 | −94.06% |
| 2023 | 2023-12-31 | $2,340 | −$45,460 | −95.10% |
| 2022 | 2022-12-31 | $47,800 | $31,833 | +199.37% |
| 2021 | 2021-12-31 | $15,967 | $15,967 | — |
| 2020 | 2020-12-31 | $0 | $0 | — |
| 2019 | 2019-12-31 | $0 | — | — |
Goldenwell Biotech quarterly revenue
Q3.19
Q1.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | $0 | — |
| Q4 2025 | 2025-12-31 | $55 | $55 | — |
| Q3 2025 | 2025-09-30 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $0 | −$139 | −100.00% |
| Q1 2025 | 2025-03-31 | $0 | −$158 | −100.00% |
| Q4 2024 | 2024-12-31 | $0 | −$260 | −100.00% |
| Q3 2024 | 2024-09-30 | $0 | −$382 | −100.00% |
| Q2 2024 | 2024-06-30 | $139 | −$137 | −49.64% |
| Q1 2024 | 2024-03-31 | $158 | −$1,264 | −88.89% |
| Q4 2023 | 2023-12-31 | $260 | $260 | — |
| Q3 2023 | 2023-09-30 | $382 | −$43,308 | −99.13% |
| Q2 2023 | 2023-06-30 | $276 | −$3,437 | −92.57% |
| Q1 2023 | 2023-03-31 | $1,422 | $1,025 | +258.19% |
| Q4 2022 | 2022-12-31 | $0 | −$2,695 | −100.00% |
| Q3 2022 | 2022-09-30 | $43,690 | $31,524 | +259.12% |
| Q2 2022 | 2022-06-30 | $3,713 | $2,607 | +235.71% |
| Q1 2022 | 2022-03-31 | $397 | $397 | — |
| Q4 2021 | 2021-12-31 | $2,695 | — | — |
| Q3 2021 | 2021-09-30 | $12,166 | $12,166 | — |
| Q2 2021 | 2021-06-30 | $1,106 | — | — |
| Q1 2021 | 2021-03-31 | $0 | $0 | — |
| Q3 2020 | 2020-09-30 | $0 | $0 | — |
| Q1 2020 | 2020-03-31 | $0 | — | — |
| Q3 2019 | 2019-09-30 | $0 | — | — |
Goldenwell Biotech revenue growth trends
Goldenwell Biotech's latest reported quarter, Q2 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Goldenwell Biotech source filings ↗